|
|
|
Corporate Profile:
Tacere Therapeutics
| Summary: |
| Tacere Therapeutics is focused on the development of RNAi therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). |
| Address (HQ): |
220 Montgomery Street
Suite 2100
San Francisco, CA 94104 |
| Phone #'s (HQ): |
| Main |
(925) 858-9299 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| not known |
| Internet
job postings: |
| not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
